Education
About Us
Working with TipRanks
Follow Us
Annovis Bio (ANVS)
NYSE:ANVS
Total Valuation
Annovis Bio has a market cap or net worth of $24.94M. The enterprise value is $58.83M.
Market Cap$24.94M
Enterprise Value$58.83M
Share Statistics
Annovis Bio has 19.49M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding19.49M
Owened by Insiders14.30%
Owened by Instutions1.62%
Financial Efficiency
Annovis Bio’s return on equity (ROE) is -2.64 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)-264.20%
Return on Assets (ROA)-176.58%
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.00%
Revenue Per Employee$0
Profits Per Employee-$1,581,288,627.25
Employee Count8
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Annovis Bio is >-0.01. Annovis Bio’s PEG ratio is >-0.01.
PE Ratio>-0.01
PS Ratio0.00
PB Ratio<0.01
Price to Fair Value<0.01
Price to FCF>-0.01
Price to Operating Cash Flow>-0.01
PEG Ratio>-0.01
Income Statement
In the last 12 months, Annovis Bio had revenue of $0.00 and earned -$12.65B in profits. Earnings per share was -$975.22.
Revenue$0.00
Gross Profit$0.00
Operating Income-$26.69M
Pretax Income-$24.59M
Net Income-$12.65B
EBITDA-26.69M
Earnings Per Share (EPS)-975.22
Cash Flow
In the last 12 months, operating cash flow was -$21.89M and capital expenditures $0.00, giving a free cash flow of -$21.89M billion.
Operating Cash Flow-$21.89M
Free Cash Flow-$21.89M
Free Cash Flow per Share-$1.12
Dividends & Yields
Annovis Bio pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-35730.05%
Earnings Yield-40129.30%
Stock Price Statistics
Beta2.52
52-Week Price Change-88.28%
50-Day Moving Average2.01
200-Day Moving Average6.38
Relative Strength Index (RSI)31.17
Average Volume (3m)270.30K
Important Dates
Annovis Bio upcoming earnings date is May 8, 2025, Before Open.
Last Earnings DateApr 8, 2025
Next Earnings DateMay 8, 2025
Ex-Dividend Date―
Financial Position
Annovis Bio as a current ratio of 2.72, with Debt / Equity ratio of 0.00
Current Ratio2.72
Quick Ratio2.72
Debt to Market Cap0.00
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Annovis Bio has paid $5.00 in taxes.
Income Tax$5.00
Effective Tax Rate0.00%
Enterprise Valuation
Annovis Bio EV to EBITDA ratio is 0.00, with an EV/FCF ratio of >-0.01.
EV to Sales0.00
EV to EBITDA0.00
EV to Free Cash Flow>-0.01
EV to Operating Cash Flow>-0.01
Balance Sheet
Annovis Bio has $10.55M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$10.55M billion.
Cash & Marketable Securities$10.55M
Total Debt$0.00
Net Cash-$10.55M
Net Cash Per Share-$0.54
Tangible Book Value Per Share$764.02
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Annovis Bio is $8.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$8.00
Price Target Upside515.38%
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast
EPS Growth Forecast68.75%